OncologyGastrointestinal Malignancy

The neuropathy your patient didn't mention is why he can't button his shirt.

Colorectal cancer treatment produces predictable toxicity patterns — fatigue crashing 3 days post-FOLFOX, neuropathy accumulating across cycles, bowel urgency limiting social life — yet these patterns are invisible between biweekly infusions and quarterly scans. The symptoms that drive dose reductions, ER visits, and quality-of-life collapse happen at home, unreported. Forma captures the daily signal across all 21 treatment domains.

How it works

15 seconds of speech. 25 data points.

Forma turns each patient into a continuous data stream. By voice or text, patients log daily bowel function, fatigue with cycle-day context, neuropathy progression, nutritional intake, GI symptoms, immunotherapy side effects, and financial burden in 20 seconds. No forms, no recall bias. The result is a structured, longitudinal dataset across all 21 CRC observation topics — fatigue trajectories mapped to cycle day, CEA and ctDNA trends paired with symptom burden, neuropathy progression visible across cycles before dose reduction becomes necessary, and the financial toxicity data that oncology trials are finally starting to measure.

Patient speaking

😊
Today

Forecast

Based on prior Topics logging

😴
Fatigue
MTWTFSS
🤗
Mood

Topics

💧
Side Effects
🔥
Pain Level
💊
Function
💧
Appetite
🔥
Fatigue
0
data points extracted
Research-Ready Dataset

Structured, coded, longitudinal

Timing
Infusion time:2:00 PM yesterdayNausea onset:8:00 PM
Severity
Nausea symptom:PresentNausea severity:6/10Emesis count:2 episodes
Actions
Treatment:ChemotherapyCycle number:3rd infusionAnti-emetic:ZofranAnti-emetic dose:8 mg
Outcome
Appetite:Absent

See Colorectal Cancer configured for your study

See Forma configured for Colorectal Cancer